Management of IBS with Alternating Constipation and Diarrhea
For patients with IBS experiencing alternating constipation and diarrhea, start with lifestyle modifications (regular exercise) and dietary interventions (soluble fiber like ispaghula 3-4g/day, gradually increased), then use tricyclic antidepressants (amitriptyline 10mg once daily, titrated to 30-50mg) as the most effective second-line treatment for global symptoms and abdominal pain, while treating the predominant bowel pattern symptomatically as it emerges.
Understanding the Alternating Subtype
The alternating subtype (IBS-M or mixed IBS) represents approximately 19-24% of IBS patients 1. Importantly, most patients with alternating symptoms actually consider themselves constipation-predominant and exhibit clinical features more similar to IBS-C than IBS-D, though they experience added defecatory urgency 1. These patients report greater abdominal discomfort/pain and more frequent physician visits compared to other IBS subtypes 1.
First-Line Management Approach
Lifestyle and Dietary Interventions
- Regular exercise: Strongly recommended for all IBS patients 2
- Soluble fiber: Start ispaghula at 3-4g/day and build up gradually to avoid bloating. This treats global symptoms and abdominal pain effectively. Avoid insoluble fiber (wheat bran) as it exacerbates symptoms 2
- Low FODMAP diet: Consider as second-line dietary therapy under dietitian supervision, with systematic reintroduction according to tolerance 2
- Probiotics: May trial for up to 12 weeks; discontinue if no improvement. No specific strain can be recommended 2
Symptom-Directed First-Line Medications
- Antispasmodics: Use for global symptoms and abdominal pain. Common side effects include dry mouth, visual disturbance, and dizziness 2
- For diarrhea-predominant phases: Loperamide, carefully titrated to avoid constipation, bloating, and nausea 2
Critical pitfall: Avoid treating alternating IBS with subtype-specific agents (like secretagogues for constipation or strong antidiarrheals) as monotherapy, as these will worsen the opposite symptom when bowel patterns shift.
Second-Line Treatment: The Neuromodulator Approach
Tricyclic Antidepressants (Preferred)
Tricyclic antidepressants are the optimal second-line choice for alternating IBS because they address global symptoms and abdominal pain regardless of bowel pattern 2. This is particularly important given that alternating patients experience more severe abdominal pain than other subtypes 1.
Dosing protocol:
- Start amitriptyline 10mg once daily at bedtime
- Titrate slowly to maximum 30-50mg once daily
- Can be initiated in primary or secondary care
- Provide careful explanation that this is used as a gut-brain neuromodulator, not for depression
- Counsel about side effects (sedation, dry mouth, constipation) 2
Strength of recommendation: Strong, with moderate quality evidence 2
Alternative Neuromodulators
- SSRIs: May be effective for global symptoms but have weaker evidence (weak recommendation, low quality evidence) 2
When Bowel Pattern Becomes Predominantly One Subtype
If the patient's symptoms shift to predominantly diarrhea or constipation for extended periods, consider adding subtype-specific agents:
For Diarrhea-Predominant Phases (Secondary Care)
Most efficacious options 2:
- 5-HT3 antagonists: Ondansetron 4mg once daily, titrated to maximum 8mg three times daily (moderate to high quality evidence). Warning: Constipation is the most common side effect—monitor closely in alternating patients
- Eluxadoline: Effective but contraindicated with prior cholecystectomy, sphincter of Oddi problems, alcohol dependence, pancreatitis, or severe liver impairment
- Rifaximin: Limited effect on abdominal pain; availability varies by country
For Constipation-Predominant Phases (Secondary Care)
Most efficacious options 2:
- Linaclotide: Most efficacious secretagogue (strong recommendation, high quality evidence). Warning: Diarrhea is common—problematic in alternating patients
- Lubiprostone: Less likely to cause diarrhea than other secretagogues, though nausea is frequent (strong recommendation, moderate quality evidence)
Critical consideration: The side effect profiles of subtype-specific medications (constipation from 5-HT3 antagonists, diarrhea from secretagogues) make them particularly challenging in alternating IBS. Use cautiously and only when one pattern clearly predominates for sustained periods.
Psychological Therapies
Gut-directed psychotherapy (cognitive behavioral therapy or hypnotherapy) should be considered, particularly given that alternating IBS patients have higher healthcare utilization and symptom burden 1, 3, 4. These can be used alongside pharmacological treatments.
Diagnostic Considerations
Before initiating treatment, ensure proper diagnosis:
- Positive symptom-based diagnosis without alarm features
- Serological testing for celiac disease
- Fecal calprotectin if inflammatory bowel disease suspected
- Consider bile acid malabsorption testing (SeHCAT or serum 7α-hydroxy-4-cholesten-3-one) if diarrhea is prominent, nocturnal, or follows cholecystectomy 2
Practical Algorithm Summary
- Start all patients: Exercise + soluble fiber + dietary advice
- Add for symptom control: Antispasmodics for pain; loperamide PRN for diarrhea phases
- Second-line backbone: Tricyclic antidepressant (amitriptyline 10-50mg daily) for global symptoms and pain
- If one pattern predominates >3 months: Consider cautious addition of subtype-specific agent, monitoring for worsening of opposite symptom
- Refractory cases: Refer to gastroenterology for psychological therapies and specialized management
The key principle is that neuromodulators treat the underlying pain and global symptoms independent of bowel pattern, making them ideal for the unpredictable nature of alternating IBS, while symptomatic agents are used judiciously and temporarily as bowel patterns shift.